May 16, 2023
Today, we are speaking to Ichor Life Sciences CEO Dr. Kelsey Moody about the doctoral program that the company operates and how the company is supporting the next generation of scientists. Ichor Life Sciences is a biotechnology company that develops and manufactures new medicines for people around the world. It is focused on creating treatments...
December 22, 2021
Woodland Biosciences, which studies metabolism and cancer, has joined the holdings of Ichor Life Sciences. Ichor intends to use Woodland's expertise and research to increase the specializations of its pharmacological division. The full press release is provided here. LaFayette, N.Y. — Ichor Life Sciences, a premium preclinical contract research organization offering services in discovery through pharmacology,...
April 11, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages of aging and may one day lead to a future without the diseases of aging. We were glad to have the opportunity to conduct a...
June 15, 2022
NEW YORK - June 15, 2022 - NOVOS, a company that develops science-based products to slow down aging, announced results of two studies demonstrating that the combination of ingredients in its products, NOVOS Core and NOVOS Boost, protect against DNA damage and cellular aging (senescence). A study found that a combination of the 12 ingredients...
January 03, 2022
2021 has come to a close, but rejuvenation biotechnology is still just beginning. Let's see what the field has accomplished in December. LEAF News Holiday Wishes from Lifespan.io: Lifespan.io president Keith Comito thanks the community of Lifespan.io for helping to bring an end to the diseases of aging, closes out the year, and looks forward...
May 06, 2021
It is always good to report on positive news for a change, and today is one of those happy occasions. Michael Greve, founder of Forever Healthy and Kizoo, has commited €300 million (just over $360 million at the time of writing) to support the development of rejuvenation biotechnology startups. More support flowing in for technology...
January 15, 2021
The world of rejuvenation biotechnology is a rapidly changing and ever developing place. As with any disruptive technology, the challenges are significant and include not only the technical aspects of developing these technologies but also the hurdles of societal acceptance of the desirability of longer, healthier lives. While I do not accept the idea proposed...
November 05, 2020
Buckminsterfullerene, also known as C60, is a remarkable molecule with a range of interesting chemical and physical properties. Several years ago, C60 came to the attention of the longevity community several years ago when a study with a small cohort of rats found that C60 dissolved in olive oil extended their lifespan [1]. This led...
August 13, 2020
With exactly one week to go before the Ending Age-Related Diseases 2020 conference begins, we have just enough time for one last update to show you what has been going on and some of the exciting things that we have planned for you to enjoy. August 20-21st will see the leading experts in aging research...
June 12, 2020
It’s halfway through the month, and a lot has been going on with the EARD 2020 conference preparations, so today is the ideal time to update you about what has been happening. Professor Lorna Harries will be joining us First things first: we are delighted to announce that Professor Lorna Harries will be speaking at...
March 23, 2019
You can download a copy of the event abstracts booklet here should you wish to do so. Day 1, Thursday, July 11th 8:00 - 9:00 Registration, Networking 9:00 - 9:10 Welcome talk by LEAF President Keith Comito 9:10 - 9:15 Welcome from Maurice Kanbar Center for Biomedical Engineering Director Oliver Medvedik 9:15 - 9:45 Opening...
November 17, 2018
Celebrating Our Second Conference We brought together leading aging researchers and biotech investors for two action-packed days of science and business. SUPPORTING AGING RESEARCH On July 11th, 2019, we hosted our second conference, Ending Age-Related Diseases 2019, at the Frederick P. Rose Auditorium, part of the Cooper Union campus in New York City. We are...
July 20, 2018
Celebrating Our First Conference We brought together leading aging researchers and biotech investors for an action-packed day of science and business. SUPPORTING AGING RESEARCH On July 12th, we hosted our first conference, Ending Age-Related Diseases 2018, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. We...
No Community Members Found.
See Content You May Be Interested In Below
Lifespan News
No Aggregator Articles Found.
See Content You May Be Interested In Below
Lifespan News
December 05, 2019
Ichor Life Sciences is a vertically integrated biopharmaceutical company occupying 2 commercial facilities with complete pre-clinical R&D capabilities in LaFayette, NY. However, the company’s beginnings were far more modest. Ichor Therapeutics was founded in 2013 by Dr. Kelsey Moody during his time as a medical student at SUNY Upstate Medical University in Syracuse, NY. Using...
June 09, 2022
Lento Bio is a preclinical pharmaceutical company focused on developing small-molecule therapeutics to target crosslinks that cause tissues to stiffen with age. The company will initially focus on developing pharmaceutical eyedrops to treat a common vision disorder, presbyopia, or age-related farsightedness. Lento Bio is supported by Ichor Life Sciences, a preclinical contract research organization. Presbyopia...
December 05, 2019
Antoxerene, Inc., a portfolio company of Ichor Therapeutics, Inc., is a pharmaceutical company that uses proprietary next generation screening technology to identify small molecule drugs for pathways of aging. At the cellular level, communication within the body occurs through protein interactions. These communication pathways can be enhanced or inhibited using small molecule compounds, which serve...
